Status:
TERMINATED
Low-Level Laser Therapy Treatment of Lung Inflammation in Post-COVID-19 Recovery
Lead Sponsor:
Ward Photonics LLC
Conditions:
COVID-19
Acute Respiratory Distress Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
An informational evaluation of COVID-19 patients who receive low-level laser therapy in addition to a normal regimen of treatment for symptoms associate with COVID-19. Results are compared to statisti...
Detailed Description
Since the emergence of COVID-19, the world has become familiar with the symptoms and acute effects of COVID-19 infection including hospitalization and death. However, we now know that COVID-19 can cau...
Eligibility Criteria
Inclusion
- Participant is diagnosed with COVID-19
- Study participant is 18 years of age or older
- Patient exhibiting moderate-to-acute respiratory distress
Exclusion
- Photosensitive condition or medication
- Active chemotherapy treatment or other cancer treatment
- Autoimmune Disorder
- Pregnant, possibly pregnant or planning pregnancy prior to the end of study participation
- Under 18
- Active cancer
- pre-existing pulmonary disease (asthma chronic bronchitis, emphasema
- Developmental disability or cognitive impairment that, in the opinion of the investigator, would preclude adequate comprehension of the informed consent form and/or ability to record the necessary study measurements
Key Trial Info
Start Date :
February 24 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 21 2022
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT05258617
Start Date
February 24 2022
End Date
November 21 2022
Last Update
November 28 2022
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
MD at Bedside
Berkeley, California, United States, 94705
2
Health Atlast
Los Angeles, California, United States, 90066
3
Longevity
Santa Monica, California, United States, 90025
4
Wellness Junction
Millsboro, Delaware, United States, 19966